钙拮抗剂预防和治疗偏头痛。

Drug design and delivery Pub Date : 1989-05-01

W K Amery

{"title":"钙拮抗剂预防和治疗偏头痛。","authors":"W K Amery","doi":"","DOIUrl":null,"url":null,"abstract":"The present review discusses the available clinical information dealing with the treatment of migraine with calcium entry blocking agents. The data on prophylactic therapy are limited to 3 compounds, of which flunarizine is the most extensively studied and the only substance whose activity is well established. Clinical experience with these agents in the acute treatment of migraine attacks is still very limited.","PeriodicalId":11271,"journal":{"name":"Drug design and delivery","volume":"4 3","pages":"197-203"},"PeriodicalIF":0.0000,"publicationDate":"1989-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prophylactic and curative treatment of migraine with calcium antagonists.\",\"authors\":\"W K Amery\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The present review discusses the available clinical information dealing with the treatment of migraine with calcium entry blocking agents. The data on prophylactic therapy are limited to 3 compounds, of which flunarizine is the most extensively studied and the only substance whose activity is well established. Clinical experience with these agents in the acute treatment of migraine attacks is still very limited.\",\"PeriodicalId\":11271,\"journal\":{\"name\":\"Drug design and delivery\",\"volume\":\"4 3\",\"pages\":\"197-203\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1989-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug design and delivery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug design and delivery","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

本综述讨论了可用的临床信息处理与钙入口阻滞剂治疗偏头痛。关于预防性治疗的数据仅限于3种化合物，其中氟桂利嗪是研究最广泛的，也是唯一具有良好活性的物质。这些药物在偏头痛发作急性治疗中的临床经验仍然非常有限。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Prophylactic and curative treatment of migraine with calcium antagonists.

The present review discusses the available clinical information dealing with the treatment of migraine with calcium entry blocking agents. The data on prophylactic therapy are limited to 3 compounds, of which flunarizine is the most extensively studied and the only substance whose activity is well established. Clinical experience with these agents in the acute treatment of migraine attacks is still very limited.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Drug design and delivery

自引率

0.00%

发文量